CXCR7 as a Novel Therapeutic Target for Advanced Prostate Cancer

The authors review and discuss the up-to-date knowledge on atypical chemokine receptor 3 (CXCR7) regulation and function and how this new understanding guides the development of CXCR7 inhibitors, focusing on prostate cancer.